Term ends no later than Mar 23, 2032 · Low confidence
20-year base term ends Mar 23, 2032
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Mar 23, 2012
Mar 23, 2032
May 5, 2015
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 23, 2012, when application 13/429,292, the earliest non-provisional in its chain, was filed (this one was filed Jan 5, 2015); a parent in its chain could not be resolved (the next row) | Mar 23, 2032 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Mar 23, 2032 | Low confidence |
This family
| US 9,028,868 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 8,927,010 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 8,916,588 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,119,809 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,034,902 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,023,389 | this patent no later than Mar 2032 | no later than Mar 2032 |
| US 9,283,214 | In force Mar 2032 | Mar 2032 |
| US 9,603,808 | In force Mar 2032 | Mar 2032 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 7, 2015 Reel 34652, frame 787 | Highland Therapeutics, Inc. | Ironshore Pharmaceuticals & Development, Inc. | Assignment of Assignor's Interest |
| Jan 7, 2015 Reel 34729, frame 571 | Formulation Technologies LLC Dba Pharmaform | Highland Therapeutics Inc. | Assignment of Assignor's Interest |
| Jan 7, 2015 Reel 34731, frame 809 | Zhang, Feng | Formulation Technologies, LLC | Assignment of Assignor's Interest |
| Jan 7, 2015 Reel 34741, frame 294 | Lickrish, David | Ironshore Pharmaceuticals & Development, Inc. | Assignment of Assignor's Interest |
| Jul 21, 2015 Reel 36140, frame 149 | Ironshore Pharmaceuticals & Development, Inc. | Eastern Capital Limited | Patent Security Agreement |
| Jan 23, 2017 Reel 41047, frame 474 | Eastern Capital Limited | Ironshore Pharmaceuticals & Development, Inc. | Release of Security Interest |
| Jan 23, 2017 Reel 41048, frame 299 | Ironshore Pharmaceuticals & Development, Inc.; Highland Therapeutics Inc.; North Sound Pharmaceuticals, Inc.; Ironshore Pharmaceuticals Inc. | U.S. Bank National Association | Security Interest |
| Sep 3, 2024 Reel 68826, frame 711 | Ironshore Pharmaceuticals & Development, Inc. | Biopharma Credit PLC | Patent Security Agreement |
| Dec 5, 2025 Reel 73133, frame 245 | U.S. Bank Trust Company, National Association | Ironshore Pharmaceuticals & Development, Inc.; Highland Therapeutics Inc.; North Sound Pharmaceuticals, Inc.; Ironshore Pharmaceuticals Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | Ironshore Pharmaceuticals & Development, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | Highland Therapeutics Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | North Sound Pharmaceuticals, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | Ironshore Pharmaceuticals Inc. | Release of Security Interest |
| Dec 23, 2025 Reel 73302, frame 334 | Collegium Pharmaceutical, Inc.; Biodelivery Sciences International, Inc.; Ironshore Pharmaceuticals & Development, Inc. | Truist Bank, a North Carolina Chartered Bank | Security Interest |
| Dec 23, 2025 Reel 73308, frame 416 | Biopharma Credit PLC | Ironshore Pharmaceuticals & Development, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Mar 23, 2032. We will not guess the cap.